| 000 | 01770 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516022917.0 | ||
| 264 | 0 | _c20110808 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1995-9133 | ||
| 024 | 7 |
_a10.1016/S1684-1182(10)60032-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShang, Shih-Ta | |
| 245 | 0 | 0 |
_aThe emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review. _h[electronic resource] |
| 260 |
_bJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi _cJun 2010 |
||
| 300 |
_a200-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aEchinocandins _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFungemia _xdiagnosis |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycoses _xdiagnosis |
| 650 | 0 | 4 |
_aOpportunistic Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSaccharomycetales _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriazoles _xtherapeutic use |
| 650 | 0 | 4 | _aVoriconazole |
| 700 | 1 | _aLin, Jung-Chung | |
| 700 | 1 | _aHo, Su-Jean | |
| 700 | 1 | _aYang, Ya-Sung | |
| 700 | 1 | _aChang, Feng-Yee | |
| 700 | 1 | _aWang, Ning-Chi | |
| 773 | 0 |
_tJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi _gvol. 43 _gno. 3 _gp. 200-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1684-1182(10)60032-1 _zAvailable from publisher's website |
| 999 |
_c20570481 _d20570481 |
||